DK0824698T3 - Anordning og fremgangsmåde til biospecifik fjernelse af heparin - Google Patents

Anordning og fremgangsmåde til biospecifik fjernelse af heparin

Info

Publication number
DK0824698T3
DK0824698T3 DK96915609T DK96915609T DK0824698T3 DK 0824698 T3 DK0824698 T3 DK 0824698T3 DK 96915609 T DK96915609 T DK 96915609T DK 96915609 T DK96915609 T DK 96915609T DK 0824698 T3 DK0824698 T3 DK 0824698T3
Authority
DK
Denmark
Prior art keywords
heparin
blood
extracorporeal
heart
heparinized
Prior art date
Application number
DK96915609T
Other languages
Danish (da)
English (en)
Inventor
Peter Grandics
Susan Szathmary
Original Assignee
Peter Grandics
Susan Szathmary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Grandics, Susan Szathmary filed Critical Peter Grandics
Application granted granted Critical
Publication of DK0824698T3 publication Critical patent/DK0824698T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK96915609T 1995-05-09 1996-05-08 Anordning og fremgangsmåde til biospecifik fjernelse af heparin DK0824698T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/437,891 US5801063A (en) 1995-05-09 1995-05-09 Device and process for the biospecific removal of heparin
PCT/US1996/006515 WO1996035954A1 (en) 1995-05-09 1996-05-08 A device and process for the biospecific removal of heparin

Publications (1)

Publication Number Publication Date
DK0824698T3 true DK0824698T3 (da) 2003-03-17

Family

ID=23738352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96915609T DK0824698T3 (da) 1995-05-09 1996-05-08 Anordning og fremgangsmåde til biospecifik fjernelse af heparin

Country Status (7)

Country Link
US (1) US5801063A (de)
EP (1) EP0824698B1 (de)
JP (1) JP3899128B2 (de)
AT (1) ATE228246T1 (de)
DE (1) DE69624914T2 (de)
DK (1) DK0824698T3 (de)
WO (1) WO1996035954A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5839443A (en) * 1996-05-16 1998-11-24 The Trustees Of Columbia University In The City Of New York Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
WO1999047190A1 (en) * 1998-03-16 1999-09-23 Medtronic, Inc. Hemostatic system and components for extracorporeal circuit
US20030069601A1 (en) * 1998-12-15 2003-04-10 Closys Corporation Clotting cascade initiating apparatus and methods of use
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
AU2002236477A1 (en) 2000-11-21 2002-06-03 The Texas A & M University System Fgf-affinity chromatography
US6761700B2 (en) * 2001-02-09 2004-07-13 Orqis Medical Corporation Extra-corporeal vascular conduit
US20100221697A1 (en) * 2005-01-12 2010-09-02 BioVec Transfusions, LLC Composition for preserving platelets and method of using and storing the same
US8129104B2 (en) * 2005-01-12 2012-03-06 Biovec Transfusion, Llc Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin
US8142992B2 (en) * 2005-01-12 2012-03-27 Biovec Transfusion, Llc Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
US7964338B2 (en) * 2005-01-12 2011-06-21 Biovec Transfusion, Llc Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier
AU2006207891C1 (en) 2005-01-28 2011-09-01 Galen Bio, Inc. Immunologically active compositions
US9095818B2 (en) * 2009-06-15 2015-08-04 Biovec Transfusion, Llc Method of filtering platelets to remove antiplatelet and anticoagulant agents
US8431334B2 (en) * 2006-01-12 2013-04-30 Biovec Transfusion, Llc Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration
WO2012162789A1 (en) * 2011-06-01 2012-12-06 University Of British Columbia Polymers for reversing heparin-based anticoagulation
TWI507641B (zh) 2012-04-17 2015-11-11 Delta Electronics Inc 照明裝置及產生白光之方法
BR112015002321A2 (pt) 2012-08-03 2019-10-22 Lfb Usa Inc uso de antitrombina recombinante
US10151749B2 (en) * 2015-08-05 2018-12-11 Alfaisal University Method and kit for the detection of microorganisms
WO2019070507A1 (en) 2017-10-05 2019-04-11 Fresenius Medical Care Holdings, Inc. POLYSULFONE-URETHANE COPOLYMER, MEMBRANES AND INCORPORATING PRODUCTS, AND METHODS OF MAKING AND USING THE SAME

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200690A (en) * 1976-12-16 1980-04-29 Millipore Corporation Immunoassay with membrane immobilized antibody
US4411786A (en) * 1979-09-07 1983-10-25 Russell Richard T Method and apparatus for separating blood from other fluids during operative procedures
US4450104A (en) * 1980-09-30 1984-05-22 Cutter Laboratories, Inc. Water insoluble gel matrix containing lectin bound to antithrombin
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US5229268A (en) * 1986-07-14 1993-07-20 Abbott Laboratories Method for diagnostic immunoassay by solid phase separation
GB9417185D0 (en) * 1994-08-25 1994-10-12 Adaptive Audio Ltd Sounds recording and reproduction systems

Also Published As

Publication number Publication date
JPH11505138A (ja) 1999-05-18
JP3899128B2 (ja) 2007-03-28
EP0824698A1 (de) 1998-02-25
US5801063A (en) 1998-09-01
EP0824698B1 (de) 2002-11-20
ATE228246T1 (de) 2002-12-15
WO1996035954A1 (en) 1996-11-14
EP0824698A4 (de) 1999-04-14
DE69624914T2 (de) 2003-09-18
DE69624914D1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
DK0824698T3 (da) Anordning og fremgangsmåde til biospecifik fjernelse af heparin
CA2243652A1 (fr) Dispositif et procede pour regler la concentration du sodium dans un liquide de dialyse en vue d'une prescription
WO2001013983A3 (en) Method and apparatus for differentially perfusing a patient during cardiopulmonary bypass
CA2077848A1 (en) Artificial kidney
DK552686D0 (da) Fremgangsmaade og apparatur til behandling af kropsvaeske, f.eks. bloddialyse
GB1503469A (en) Needle for hemodialysis
ATE355092T1 (de) Verfahren und vorrichtung zur erfassung der abtrennung der venösen nadel von einem patienten während der dialyse
SE8502757D0 (sv) System for styrning av dialys
ATE28571T1 (de) Schlauchsystem zur behandlung von blut ausserhalb des koerpers and aehnlichen leichtverderblichen fluessigkeiten.
IT9067168A0 (it) Apparecchiatura per la depurazione del sangue, particolarmente per il trattamento di pazienti affetti da insufficienza renale, e procedimentoo per produzione di liquido di reinfusione per emodiafiltrazione (hdf)
IT8722399A0 (it) Metodo per prevenire la formazionedi coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso.
WO1990012607A1 (en) Antithrombotic blood treating system
SE8800758L (sv) Anordning foer tryckoeverfoering
SE9300728D0 (sv) Saett att maeta effekten av en dialysbehandling
AU2003208321A1 (en) Method and device for determining the hematocrit and/or blood volume
US5709993A (en) Process for anticoagulation during extracorporeal blood circulation sequentially using citrate or nafamostat and heparin
DE3372711D1 (en) A tube set intended for extracorporeal treatment of blood and similar perishable liquids
IT1244805B (it) Circuito extracorporeo di plasmaferesi ad ago singolo
DE69101654D1 (de) Detektor für den Abfluss einer ersten Flüssigkeit im Kreislauf einer zweiten Flüssigkeit.
EP0400518A3 (de) Autotransfusionssystem für das Sammeln, die Behandlung und die Rückführung von Blut eines Patienten
IT8240004A0 (it) Extracorporeo dispositivo per il pompaggio del sangue nel processo di dialisi
Ryanc et al. Recovery from ischemic acute renal failure: independence from dialysis membrane type
ATE307596T1 (de) Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
Vanholder et al. Single needle haemodialysis
Knudsen et al. Functional Impairment of Protein C Activity during Haemodialysis-A New Mechanism of Extracorporeal Thrombogenesis